ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2021

The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type 2 Diabetes and Established Cardiovascular Disease.

Lars Holger Ehlers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.